Related references
Note: Only part of the references are listed.Diverse pathological implications of YKL-40: Answers may lie in 'outside-in' signaling
Mansi Prakash et al.
CELLULAR SIGNALLING (2013)
Effects of Natalizumab Treatment on the Cerebrospinal Fluid Proteome of Multiple Sclerosis Patients
Marcel P. Stoop et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis
Laura F. Dagley et al.
PROTEOMICS CLINICAL APPLICATIONS (2013)
Astrocyte and Macrophage Regulation of YKL-40 Expression and Cellular Response in Neuroinflammation
Dafna Bonneh-Barkay et al.
BRAIN PATHOLOGY (2012)
Two Closely Related Human Members of Chitinase-like Family, CHI3L1 and CHI3L2, Activate ERK1/2 in 293 and U373 Cells but Have the Different Influence on Cell Proliferation
Pavlo O. Areshkov et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis
E. Canto et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
LETHAL MULTIPLE SCLEROSIS RELAPSE AFTER NATALIZUMAB WITHDRAWAL
Valerie Rigau et al.
NEUROLOGY (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury
Chun Geun Lee et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Biomarkers of disease activity in multiple sclerosis
Jerome J. Graber et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
J. Kuhle et al.
NEUROLOGY (2011)
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
Manuel Comabella et al.
BRAIN (2010)
In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases
Dafna Bonneh-Barkay et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
Jan Ottervald et al.
JOURNAL OF PROTEOMICS (2010)
Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis
Marcel P. Stoop et al.
PLOS ONE (2010)
Quantitative Matrix-Assisted Laser Desorption Ionization-Fourier Transform Ion Cyclotron Resonance (MALDI-FT-ICR) Peptide Profiling and Identification of Multiple-Sclerosis-Related Proteins
Marcel P. Stoop et al.
JOURNAL OF PROTEOME RESEARCH (2009)
CSF proteome analysis in clinically isolated syndrome (CIS): Candidate markers for conversion to definite multiple sclerosis
H. Tumani et al.
NEUROSCIENCE LETTERS (2009)
YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor
Dafna Bonneh-Barkay et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis
D. Chiasserini et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry
Marcel P. Stoop et al.
PROTEOMICS (2008)
Cerebrospinal fluid proteome profile in multiple sclerosis
V. Lehmensiek et al.
MULTIPLE SCLEROSIS (2007)
Lumbar cerebrospinal fluid proteome in multiple sclerosis: Characterization by ultrafiltration, liquid chromatography, and mass spectrometry
Jean-Paul Noben et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis
J Brettschneider et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
MRI criteria for dissemination in space in patients with clinically isolated syndromes:: a multicentre follow-up study
T Korteweg et al.
LANCET NEUROLOGY (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement
C Nordenbæk et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2005)
Increased serum YKL-40 in patients with pulmonary sarcoidosis - a potential marker of disease activity?
JS Johansen et al.
RESPIRATORY MEDICINE (2005)
Proteomic analysis of multiple sclerosis cerebrospinal fluid
BN Hammack et al.
MULTIPLE SCLEROSIS (2004)
Proteomic analysis of astrocytic secretion in the mouse -: Comparison with the cerebrospinal fluid proteome
M Lafon-Cazal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Dynamics of brain-derived proteins in cerebrospinal fluid
H Reiber
CLINICA CHIMICA ACTA (2001)
Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis
T Sekine et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Share Paper
